Follow
Peter E Fecci, M.D., Ph.D.
Peter E Fecci, M.D., Ph.D.
Professor of Neurosurgery, Pathology, Immunology, and Biomedical Engineering; at Duke University
Verified email at duke.edu
Title
Cited by
Cited by
Year
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
S Koyama, EA Akbay, YY Li, GS Herter-Sprie, KA Buczkowski, ...
Nature communications 7 (1), 10501, 2016
14062016
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors
EA Akbay, S Koyama, J Carretero, A Altabef, JH Tchaicha, ...
Cancer discovery 3 (12), 1355-1363, 2013
12892013
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma
PE Fecci, DA Mitchell, JF Whitesides, W Xie, AH Friedman, GE Archer, ...
Cancer research 66 (6), 3294-3302, 2006
6372006
STK11/LKB1 deficiency promotes neutrophil recruitment and proinflammatory cytokine production to suppress T-cell activity in the lung tumor microenvironment
S Koyama, EA Akbay, YY Li, AR Aref, F Skoulidis, GS Herter-Sprie, ...
Cancer research 76 (5), 999-1008, 2016
5072016
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
P Chongsathidkiet, C Jackson, S Koyama, F Loebel, X Cui, SH Farber, ...
Nature medicine 24 (9), 1459-1468, 2018
4842018
T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma
K Woroniecka, P Chongsathidkiet, K Rhodin, H Kemeny, C Dechant, ...
Clinical Cancer Research 24 (17), 4175-4186, 2018
4752018
Brain immunology and immunotherapy in brain tumours
JH Sampson, MD Gunn, PE Fecci, DM Ashley
Nature Reviews Cancer 20 (1), 12-25, 2020
4522020
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function
PE Fecci, H Ochiai, DA Mitchell, PM Grossi, AE Sweeney, GE Archer, ...
Clinical cancer research 13 (7), 2158-2167, 2007
3762007
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
AJ Giles, MKND Hutchinson, HM Sonnemann, J Jung, PE Fecci, ...
Journal for immunotherapy of cancer 6, 1-13, 2018
3702018
T-cell dysfunction in glioblastoma: applying a new framework
KI Woroniecka, KE Rhodin, P Chongsathidkiet, KA Keith, PE Fecci
Clinical Cancer Research 24 (16), 3792-3802, 2018
2332018
Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model
TA Cheema, H Wakimoto, PE Fecci, J Ning, T Kuroda, DS Jeyaretna, ...
Proceedings of the National Academy of Sciences 110 (29), 12006-12011, 2013
2092013
Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells
PE Fecci, AE Sweeney, PM Grossi, SK Nair, CA Learn, DA Mitchell, X Cui, ...
Clinical Cancer Research 12 (14), 4294-4305, 2006
2052006
Immune suppression in gliomas
MM Grabowski, EW Sankey, KJ Ryan, P Chongsathidkiet, SJ Lorrey, ...
Journal of neuro-oncology 151, 3-12, 2021
1912021
A review of glioblastoma immunotherapy
R Medikonda, G Dunn, M Rahman, P Fecci, M Lim
Journal of neuro-oncology 151, 41-53, 2021
1902021
Leptomeningeal disease: current diagnostic and therapeutic strategies.
G Nayar, T Ejikeme, P Chongsathidkiet, AA Elsamadicy, KL Blackwell, ...
Oncotarget 8 (42), 73312-73328, 2017
1602017
Sequential immunotherapy by vaccination with GM-CSF–expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors
P Agarwalla, Z Barnard, P Fecci, G Dranoff, WT Curry Jr
Journal of immunotherapy 35 (5), 385-389, 2012
1252012
CD4 T-cell exhaustion: does it exist and what are its roles in cancer?
AM Miggelbrink, JD Jackson, SJ Lorrey, ES Srinivasan, J Waibl-Polania, ...
Clinical Cancer Research 27 (21), 5742-5752, 2021
1162021
Immunotherapy of malignant brain tumors
DA Mitchell, PE Fecci, JH Sampson
Immunological reviews 222 (1), 70-100, 2008
1152008
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
Y Mei, WL Bi, NF Greenwald, Z Du, NYR Agar, UB Kaiser, ...
Oncotarget 7 (47), 76565, 2016
1142016
Immunotherapy for primary brain tumors: no longer a matter of privilege
PE Fecci, AB Heimberger, JH Sampson
Clinical cancer research 20 (22), 5620-5629, 2014
1122014
The system can't perform the operation now. Try again later.
Articles 1–20